Get Premium to unlock powerful stock data
NAS:BLUE (USA)  
bluebird bio Inc logo

bluebird bio Inc

$ 4.28 +0.14 (+3.38%) 08:08 PM EST
P/E:
At Loss
P/B:
1.16
Market Cap:
$ 305.82M
Enterprise V:
$ 204.57M
Volume:
3.99M
Avg Vol (2M):
8.22M
Also Trade In:
Volume:
3.99M
Market Cap $:
305.82M
PE Ratio:
At Loss
Avg Vol (2-Month):
8.22M
Enterprise Value $:
204.57M
PB Ratio:
1.16
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Description
bluebird bio Inc is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaboration arrangements, research fees, license fees, and grant revenue. The company works with industry peers, strategic partners, and nonprofit organizations for the development and commercialization of its product candidates.
Name Current Vs Industry Vs History
Cash-To-Debt 1.92
Equity-to-Asset 0.54
Debt-to-Equity 0.42
Debt-to-EBITDA -0.25
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -13.11
Distress
Grey
Safe
Beneish M-Score -5.25
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 54.24
9-Day RSI 55.84
14-Day RSI 55.27
6-1 Month Momentum % -70.27
12-1 Month Momentum % -85.85

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.78
Quick Ratio 1.78
Cash Ratio 1.48
Days Inventory 87.51
Days Payable 220.25

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -9.1

Financials (Next Earnings Date:2022-08-09 Est.)

BLUE's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:BLUE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) -7.187
EPS (TTM) ($) -10.54
Beta 1.37
Volatility % 70.02
14-Day RSI 55.27
14-Day ATR ($) 0.526315
20-Day SMA ($) 3.876
12-1 Month Momentum % -85.85
52-Week Range ($) 2.865 - 21.077612
Shares Outstanding (Mil) 71.45

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

bluebird bio Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More